Large gap with delayed quotes
|
Last quote
11/04/2025
-
02:00:00
|
Bid
11/04/2025 -
13:03:15
|
Bid Volume |
Ask
11/04/2025 -
13:03:15
|
Ask Volume |
|---|---|---|---|---|
|
94.81
+0.23
(
+0.24% )
|
84.99
|
100 |
102.71
|
100 |
Analysis date: 31.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 22.07.2025.
Interest
Weak
Weak
Two stars since 28.10.2025.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 05.09.2025 at a price of 91.48.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 21.10.2025.
4wk Rel Perf
-2.47%
-2.47%
The four-week dividend-adjusted underperformance versus SP500 is 2.47%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 22.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.67%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.28%.
Mkt Cap in $bn
8.15
8.15
With a market capitalization >$8bn, HEALTHEQUITY is considered a large-cap stock.
G/PE Ratio
0.95
0.95
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
20.25
20.25
The estimated PE is for the year 2027.
LT Growth
19.13%
19.13%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
95
95
For 1% of index variation, the stock varies on average by 0.95%.
Correlation
0.49
0.49
48.86% of stock movements are explained by index variations.
Value at Risk
19.28
19.28
The value at risk is estimated at USD 19.28. The risk is therefore 20.38%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.05.2017
02.05.2017